The National Institute on Drug Abuse offers the Cutting-Edge Basic Research Award (CEBRA) to support innovative research on substance use disorders (SUDs). This grant encourages high-risk, high-impact projects that have the potential to revolutionize SUD research by developing new techniques or testing groundbreaking hypotheses. Applicants should propose research that is not currently represented in NIDA’s portfolio and that could lead to significant advancements in the understanding and treatment of SUDs. The deadline for submissions is August 14, 2024.
Opportunity ID: 332394
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-208 |
| Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Mar 26, 2021 |
| Last Updated Date: | Mar 20, 2024 |
| Original Closing Date for Applications: | Feb 15, 2024 |
| Current Closing Date for Applications: | Aug 14, 2024 |
| Archive Date: | Sep 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts For profit organizations other than small businesses County governments Special district governments Public housing authorities/Indian housing authorities City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date as per NOT-DA-23-062 | Mar 20, 2024 | |
| updated close date as per NOT-DA-21-043 | Mar 26, 2021 | |
| Mar 26, 2021 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-208 |
| Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Mar 26, 2021 |
| Last Updated Date: | Mar 20, 2024 |
| Original Closing Date for Applications: | Feb 15, 2024 |
| Current Closing Date for Applications: | Aug 14, 2024 |
| Archive Date: | Sep 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts For profit organizations other than small businesses County governments Special district governments Public housing authorities/Indian housing authorities City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-208 |
| Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 26, 2021 |
| Last Updated Date: | Mar 31, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 08, 2024 |
| Archive Date: | Apr 07, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Independent school districts State governments City or township governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-208 |
| Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 26, 2021 |
| Last Updated Date: | Mar 26, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 15, 2024 |
| Archive Date: | Mar 22, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Independent school districts City or township governments State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
Folder 332394 Full Announcement-PAR-21-208 -> PAR-21-208-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00266178 | Jul 10, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270312 | Nov 16, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278128 | Nov 08, 2022 | Aug 14, 2024 | View |
Package 1
Mandatory forms
332394 RR_SF424_2_0-2.0.pdf
332394 PHS398_CoverPageSupplement_5_0-5.0.pdf
332394 RR_OtherProjectInfo_1_4-1.4.pdf
332394 PerformanceSite_2_0-2.0.pdf
332394 RR_KeyPersonExpanded_2_0-2.0.pdf
332394 PHS398_ResearchPlan_4_0-4.0.pdf
332394 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332394 RR_Budget_1_4-1.4.pdf
332394 RR_SubawardBudget30_1_4-1.4.pdf
332394 PHS398_ModularBudget_1_2-1.2.pdf
332394 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
332394 RR_SF424_5_0-5.0.pdf
332394 PHS398_CoverPageSupplement_5_0-5.0.pdf
332394 RR_OtherProjectInfo_1_4-1.4.pdf
332394 PerformanceSite_4_0-4.0.pdf
332394 RR_KeyPersonExpanded_4_0-4.0.pdf
332394 PHS398_ResearchPlan_4_0-4.0.pdf
332394 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332394 RR_Budget_3_0-3.0.pdf
332394 RR_SubawardBudget30_3_0-3.0.pdf
332394 PHS398_ModularBudget_1_2-1.2.pdf
332394 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
332394 RR_SF424_5_0-5.0.pdf
332394 PHS398_CoverPageSupplement_5_0-5.0.pdf
332394 RR_OtherProjectInfo_1_4-1.4.pdf
332394 PerformanceSite_4_0-4.0.pdf
332394 RR_KeyPersonExpanded_4_0-4.0.pdf
332394 PHS398_ResearchPlan_5_0-5.0.pdf
332394 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332394 RR_Budget_3_0-3.0.pdf
332394 RR_SubawardBudget30_3_0-3.0.pdf
332394 PHS398_ModularBudget_1_2-1.2.pdf
332394 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
